Phillip Fleshner

10.9k total citations · 2 hit papers
169 papers, 6.4k citations indexed

About

Phillip Fleshner is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Phillip Fleshner has authored 169 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Surgery, 88 papers in Genetics and 70 papers in Epidemiology. Recurrent topics in Phillip Fleshner's work include Inflammatory Bowel Disease (86 papers), Microscopic Colitis (60 papers) and Diverticular Disease and Complications (42 papers). Phillip Fleshner is often cited by papers focused on Inflammatory Bowel Disease (86 papers), Microscopic Colitis (60 papers) and Diverticular Disease and Complications (42 papers). Phillip Fleshner collaborates with scholars based in United States, Canada and United Kingdom. Phillip Fleshner's co-authors include Stephan R. Targan, Konstantinos A. Papadakis, Dermot McGovern, Marla C. Dubinsky, Karen Zaghiyan, Eric A. Vasiliauskas, Kent D. Taylor, Jerome I. Rotter, Carol J. Landers and Gil Melmed and has published in prestigious journals such as Science, Cell and SHILAP Revista de lepidopterología.

In The Last Decade

Phillip Fleshner

162 papers receiving 6.3k citations

Hit Papers

Disease-Specific Alterati... 2012 2026 2016 2021 2015 2012 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Phillip Fleshner United States 38 2.5k 2.2k 2.1k 1.6k 970 169 6.4k
Miles Parkes United Kingdom 36 2.8k 1.1× 1.1k 0.5× 1.5k 0.7× 1.8k 1.1× 726 0.7× 128 5.5k
Ellen Scherl United States 34 2.0k 0.8× 1.1k 0.5× 1.5k 0.7× 1.6k 0.9× 922 1.0× 170 5.1k
Klaus Fellermann Germany 42 2.6k 1.0× 1.1k 0.5× 1.4k 0.7× 2.5k 1.5× 749 0.8× 103 6.9k
Epameinondas V. Tsianos Greece 34 1.5k 0.6× 1.2k 0.5× 3.0k 1.5× 590 0.4× 268 0.3× 179 6.3k
Tim Raine United Kingdom 29 2.8k 1.1× 1.0k 0.5× 2.0k 1.0× 776 0.5× 344 0.4× 97 4.9k
Ingrid Arijs Belgium 36 2.7k 1.1× 1.3k 0.6× 1.8k 0.9× 2.4k 1.4× 1.9k 1.9× 75 7.0k
Yashwant R. Mahida United Kingdom 36 1.4k 0.6× 962 0.4× 1.0k 0.5× 1.1k 0.7× 663 0.7× 91 4.6k
Peter Mannon United States 31 1.6k 0.6× 1.0k 0.5× 935 0.5× 1.7k 1.1× 666 0.7× 71 6.2k
Miquel A. Gassull Spain 35 3.8k 1.5× 2.1k 0.9× 3.2k 1.5× 1.7k 1.1× 681 0.7× 81 8.3k
Tadakazu Hisamatsu Japan 47 3.7k 1.5× 1.7k 0.8× 2.5k 1.2× 1.8k 1.1× 571 0.6× 294 8.3k

Countries citing papers authored by Phillip Fleshner

Since Specialization
Citations

This map shows the geographic impact of Phillip Fleshner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Fleshner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Fleshner more than expected).

Fields of papers citing papers by Phillip Fleshner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Fleshner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Fleshner. The network helps show where Phillip Fleshner may publish in the future.

Co-authorship network of co-authors of Phillip Fleshner

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Fleshner. A scholar is included among the top collaborators of Phillip Fleshner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Fleshner. Phillip Fleshner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuckerman, Jesse, Anthony de Buck van Overstraeten, Gil Melmed, et al.. (2025). Improvement in Functional Outcomes Following Ileal Pouch-Anal Anastomosis: Results from the United States Ileal Pouch-Anal Anastomosis Study. Diseases of the Colon & Rectum. 68(11). 1315–1326.
2.
3.
Assaf, Dan, et al.. (2024). Has the Use of Enhanced Recovery Protocols in Colorectal Surgery Increased Postoperative Bleeding Complications?. Diseases of the Colon & Rectum. 68(3). 366–372. 1 indexed citations
4.
Truong, Adam, et al.. (2023). Feasibility of opioid‐free surgery for inflammatory bowel disease. Colorectal Disease. 25(5). 976–983. 2 indexed citations
5.
Adams, E. D., Karen Zaghiyan, & Phillip Fleshner. (2023). End-to-end stapled technique for Kono-S anastomosis. Techniques in Coloproctology. 27(12). 1383–1386. 1 indexed citations
6.
Adams, E. D., Jean F. Salem, Miguel Burch, Phillip Fleshner, & Karen Zaghiyan. (2023). Blinded Intraoperative Quantitative Indocyanine Green Metrics Associate With Intestinal Margin Acceptance in Colorectal Surgery. Diseases of the Colon & Rectum. 67(4). 549–557. 4 indexed citations
8.
Park, Lisa, Karen Zaghiyan, & Phillip Fleshner. (2021). Transanal Ileal Pouch: Is It Better?. Journal of Laparoendoscopic & Advanced Surgical Techniques. 31(8). 898–904. 6 indexed citations
9.
Truong, Adam, et al.. (2020). Clinical Factors Associated With Response to Fecal Diversion in Crohn’s Disease. The American Surgeon. 86(10). 1277–1280. 2 indexed citations
10.
Truong, Adam, et al.. (2020). Long-term healing after complex anal fistula repair in patients with Crohn’s disease. Techniques in Coloproctology. 24(8). 833–841. 13 indexed citations
11.
Truong, Adam, et al.. (2019). A Standardized Multimodal Analgesia Protocol Reduces Perioperative Opioid Use in Minimally Invasive Colorectal Surgery. Journal of Gastrointestinal Surgery. 24(10). 2286–2294. 31 indexed citations
12.
Potdar, Alka A., Dalin Li, Talin Haritunians, et al.. (2019). Ileal Gene Expression Data from Crohn’s Disease Small Bowel Resections Indicate Distinct Clinical Subgroups. Journal of Crohn s and Colitis. 13(8). 1055–1066. 14 indexed citations
13.
Truong, Adam, Karen Zaghiyan, & Phillip Fleshner. (2019). Anorectal Crohn's Disease. Surgical Clinics of North America. 99(6). 1151–1162. 8 indexed citations
14.
Gonsky, Rivkah, Phillip Fleshner, Richard L. Deem, et al.. (2017). Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn’s Disease. Gastroenterology. 153(1). 219–232. 20 indexed citations
15.
Xu, Chunlan, David Q. Shih, Elaine C. Lee, et al.. (2017). CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway. Scientific Reports. 7(1). 16351–16351. 11 indexed citations
16.
Zaghiyan, Karen, Gil Melmed, Eric Vasiliauskas, et al.. (2016). Outcomes with Anti-Tumour Necrosis Factor-Alpha Therapy and Serology in Patients withDenovoCrohn’s Disease After Ileal Pouch Anal Anastomosis. Journal of Crohn s and Colitis. 11(1). 77–83. 20 indexed citations
17.
Iliev, Iliyan D., Vincent Funari, Kent D. Taylor, et al.. (2012). Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis. Science. 336(6086). 1314–1317. 827 indexed citations breakdown →
18.
Saruta, Masayuki, Qi Yu, Armine Avanesyan, et al.. (2007). Phenotype and Effector Function of CC Chemokine Receptor 9-Expressing Lymphocytes in Small Intestinal Crohn’s Disease. The Journal of Immunology. 178(5). 3293–3300. 81 indexed citations
19.
Yu, Qi, Masayuki Saruta, Armine Avanesyan, et al.. (2006). Expression and functional characterization of FOXP3+CD4+ regulatory T cells in ulcerative colitis. Inflammatory Bowel Diseases. 13(2). 191–199. 154 indexed citations
20.
Fleshner, Phillip, David J. Schoetz, Patricia L. Roberts, et al.. (1995). Anal fissure in Crohn's disease. Diseases of the Colon & Rectum. 38(11). 1137–1143. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026